This review focusses on the use of Secukinumabin moderate-to-severe plaque psoriasis. Guiding commentary has been supplied by Professor Rodney Sinclair, Director of Dermatology at the Epworth Hospital, and Professor of Dermatology at the University of Melbourne.
Please login below to download this issue (PDF)